30
Participants
Start Date
July 15, 2024
Primary Completion Date
September 30, 2026
Study Completion Date
November 16, 2026
Atezolizumab
Atezolizumab will be administered at a dose of 1200 mg by IV infusion on Day 1 of each 21-day cycle.
Bevacizumab
Bevacizumab will be administered at a dose of 15 mg/kg by IV infusion on Day 1 of each 21-day cycle.
RECRUITING
Icahn School of Medicine at Mount Sinai, New York
RECRUITING
Montefiore Medical Center, The Bronx
RECRUITING
Veterans Affairs Pittsburgh Healthcare System - NAVREF - PPDS, Pittsburgh
RECRUITING
Thomas Jefferson University, Philadelphia
RECRUITING
Inova Schar Cancer Institute, Falls Church
RECRUITING
Maryview Hospital, Inc., Newport News
RECRUITING
Levine Cancer Institute, Charlotte
RECRUITING
Orlando Health Inc., Orlando
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Veterans Affairs Ann Arbor Healthcare System, Ann Arbor
RECRUITING
Barbara Ann Karmanos Cancer Institute, Detroit
RECRUITING
Henry Ford Health System, Detroit
RECRUITING
Saint Luke?s Hospital of Kansas City, Kansas City
RECRUITING
LSU Health Baton Rouge, Baton Rouge
RECRUITING
Moody Outpatient Center ? Parkland Health, Dallas
RECRUITING
Houston Methodist Hospital, Houston
RECRUITING
Intermountain Cancer Center, St. George
RECRUITING
University of Arizona Cancer Center, Tucson
RECRUITING
UC San Diego Moores Cancer Center, La Jolla
RECRUITING
University of Southern California, Newport Beach
COMPLETED
University of California Irvine Medical Center, Orange
RECRUITING
Stanford Health Care, Stanford
RECRUITING
University of California Davis Medical Center, Sacramento
RECRUITING
Virginia Mason Medical Center, Seattle
RECRUITING
University of Southern California-Keck School of Medicine -1975 Zonal Ave, Los Angeles
RECRUITING
California Liver Research Institute, Pasadena
RECRUITING
Harbor UCLA Medical Center, Torrance
RECRUITING
Cedars Sinai Comprehensive Transplant Center, West Hollywood
RECRUITING
Rocky Mountain Cancer Centers (Williams) - USOR, Denver
RECRUITING
Hartford Healthcare Cancer Institute at Hartford Hospital, Hartford
RECRUITING
Washington DC VA Medical Center, Washington D.C.
RECRUITING
Northwestern University, Chicago
RECRUITING
University of Illinois Health Outpatient Care Center, Chicago
RECRUITING
The Duchossois Center for Advanced Medicine, Chicago
RECRUITING
University of Kentucky - Markey Cancer Center, Lexington
RECRUITING
Our Lady of the Lake Physician Group, Baton Rouge
RECRUITING
Tufts Medical Center, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
MorristownMedicalCenter, Morristown
RECRUITING
Rutgers Cancer Institute of New Jersey, New Brunswick
RECRUITING
Rutgers Cancer Institute of New Jersey at University Hospital, Newark
RECRUITING
Long Island Heart Associates, Mineola
RECRUITING
R.J. Zuckerberg Cancer Hospital/Northwell Health - BRANY - PPDS, New Hyde Park
RECRUITING
NYU Langone Medical Center, New York
RECRUITING
James J Peters Veterans Administration Medical Center - NAVREF, The Bronx
RECRUITING
Dayton VA Medical Center - NAVREF - PPDS, Dayton
RECRUITING
The University of Oklahoma Health Sciences Center, Oklahoma City
RECRUITING
Kaiser Permanente Westside Medical Center, Hillsboro
RECRUITING
OHSU Knight Cancer Institute Hematology Oncology, Portland
RECRUITING
The West Clinic (East Campus), Germantown
RECRUITING
Nashville General Hospital at Meharry, Nashville
RECRUITING
Liver Institute at Methodist Dallas, Dallas
RECRUITING
Texas Oncology (Worth) - USOR, Dallas
RECRUITING
University of Texas Southwestern Medical Center, Dallas
RECRUITING
Texas Oncology - Denison Cancer Center, Denison
RECRUITING
Kelsey Research Foundation, Houston
RECRUITING
Michael E Debakey VA Medical Center - NAVREF - PPDS, Houston
RECRUITING
Intermountain Healthcare, Murray
RECRUITING
Bon Secours St. Mary's Hospital, Richmond
RECRUITING
VCU Medical Center North Hospital, Richmond
RECRUITING
Pan American Center for Oncology Trials, LLC, Rio Piedras
Lead Sponsor
Genentech, Inc.
INDUSTRY